"MON-LB110 A Phase 2 Evaluation of a Ready-To-Use Liquid Stable Continuous Subcutaneous Glucagon Infusion for the Treatment of Hypoglycemia Associated Autonomic Failure" by Jeremy H Pettus

Selected Works of Samer Nakhle, MD, FACE

Article

MON-LB110 A Phase 2 Evaluation of a Ready-To-Use Liquid Stable Continuous Subcutaneous Glucagon Infusion for the Treatment of Hypoglycemia Associated Autonomic Failure

Journal of the Endocrine Society (2020)

Jeremy H Pettus, University of California, San Diego
Samer Nakhle, Palm Medical Group, LAS VEGAS, NV, USA
Fernando Ovalle, University of Alabama at Birmingham
Michael Roehrhoff Rickels, University of Pennsylvania
Guillermo Enrique Umpierrez, Emory University
Khaled Junaidi, Xeris Pharmaceuticals, Chicago, IL, USA
Nicole C Close, Xeris Pharmaceuticals, Chicago, IL, USA
Anh Nguyen, Xeris Pharmaceuticals, Chicago, IL, USA

Link

Disciplines

Publication Date

May 8, 2020

DOI

10.1210/JENDSO/BVAA046.2331

Citation Information

Jeremy H Pettus, Samer Nakhle, Fernando Ovalle, Michael Roehrhoff Rickels, et al.. "MON-LB110 A Phase 2 Evaluation of a Ready-To-Use Liquid Stable Continuous Subcutaneous Glucagon Infusion for the Treatment of Hypoglycemia Associated Autonomic Failure" Journal of the Endocrine Society Vol. 4 (2020)
Available at: http://works.bepress.com/samer-nakhle/8/